Quell Therapeutics

Uncover our world leading platform

Uncover our world leading platform

On the pursuit to develop the most stable and potent targeted Treg cell therapies

Quell Slider 2

Tregs

The masters of immune tolerance

Regulatory T cells (Tregs) are the body's masterful immune modulators, expertly orchestrating the immune system to strike the perfect balance between immune defence and self tolerance

Our Platform

with the optimal cell product at our core and a suite of innovative technologies to ensure continued trailblazing progress

Shubham dhage z Qtevc V X Ro unsplash

Innovation Platform

Off the Shelf Treg Therapy
Faster, simpler and lower cost

Quell's iPSC allogeneic platform is set to revolutionize future cell therapies by providing a scalable, off-the-shelf Treg cell therapy solution. This ground-breaking platform harnesses the power of induced pluripotent stem cells to create universally dosable Treg cells - a faster, simpler and lower cost product to allow broader accessibility to a wider range of immune-mediated diseases.

Manufacturing Process

We are a clinical stage company at the forefront of the Treg cell therapy field. With deep GMP experience and over several hundred scale runs to date, we pride ourselves on the continued delivery of the highest manufacturing standards. Our experience at therapeutic scale has driven significant improvements, making our manufacturing process highly efficient, stable, and effective for delivering transformative cell products to patients.